Showing 1,561 - 1,580 results of 112,505 for search '(( 6 b decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.42s Refine Results
  1. 1561
  2. 1562
  3. 1563
  4. 1564

    Anti-TGFβ antibody treatment decreases tumor burden in tumor-bearing mice. by Swati Biswas (73661)

    Published 2013
    “…<p><b>Panel a:</b> Representative H&E sections (5×) of tibia from tumor-bearing mice treated with control antibody (13C4) or anti-TGFβ antibody (1D11). …”
  5. 1565
  6. 1566

    Oral administration of BV decreased infiltrated inflammatory cells in BALF of asthmatic mice models. by Ran Fu (434520)

    Published 2014
    “…(B), The infiltrated eosinophils, neutrophils and other inflammatory cells were significantly decreased in BALF of asthmatic mice models in 2 monBV/OVA/OVA group. …”
  7. 1567
  8. 1568
  9. 1569

    miR-124 decreases cell proliferation in 2D and 3D cultures. by Alexa Tenga (2161780)

    Published 2016
    “…As a result, Nur77 mRNA levels were significantly decreased (<i>p</i> < 0.0001). …”
  10. 1570
  11. 1571
  12. 1572
  13. 1573

    Decreased thrombin activity levels in PAR KO following 24 hours following ischemia. by Efrat Shavit-Stein (3186678)

    Published 2021
    “…<p>(A) Total thrombin activity is significantly decreased in PAR1 KO compared to WT mice (t-test). …”
  14. 1574
  15. 1575
  16. 1576

    Severe decreases of TECs and impaired TEC expansion in the absence of mTORC1/Raptor. by Hong-Xia Wang (288934)

    Published 2016
    “…<b>f.</b> mTORC1 dependent S6 phosphorylation in TECs. …”
  17. 1577
  18. 1578

    Patients with NDO have decreased BKα subunit mRNA expression in DSM. by Kiril L. Hristov (431003)

    Published 2013
    “…<p>qPCR analyses showing 15.8-fold, 1.1-fold, and 1.6-fold decreases in BKα (<b>A</b>), BKβ1 (<b>B</b>), and BKβ4 subunits (<b>C</b>) mRNA expression in NDO DSM tissue (n = 3, N = 3) compared to controls (n = 7, N = 7; **P<0.01). …”
  19. 1579

    ADAM9 reduction therapy decreased tumor volume by inhibiting cancer cell proliferation. by Che-Ming Liu (102604)

    Published 2013
    “…(c) Immunoblotting assay of ADAM9 expression confirms decreased ADAM9 expression after shADAM9 therapy. EF-1α was used as a loading control (* <i>p</i>≤0.05; ** <i>p</i>≤0.01, Student’s <i>t</i> test). …”
  20. 1580